Meropenem Sun

Meropenem, the active ingredient in Meropenem Sun, is a carbapenem antibiotic presented as an injectable formulation for intravenous use. It provides broad‑spectrum antibacterial activity against Gram‑negative and Gram‑positive pathogens and is employed in severe hospital‑acquired infections.

GNH USA supplies Meropenem Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to stringent quality standards and delivering the product across multiple continents.

Meropenem is used to treat serious bacterial infections that affect the abdominal, urinary, respiratory and central nervous systems.

Complicated intra‑abdominal infections: eliminates causative bacteria and improves clinical outcomes. Complicated urinary tract infections: eradicates resistant uropathogens and resolves infection. Nosocomial pneumonia: provides rapid bacterial clearance in hospital‑acquired lung infections. Septicemia: achieves systemic bacterial control and reduces mortality risk. Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis effectively.

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects: - Nausea or vomiting - Diarrhea, including mild C. difficile‑associated colitis - Headache - Infusion site erythema or phlebitis

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment - Anaphylactic or severe hypersensitivity reactions - Severe C. difficile‑associated colitis - Neutropenia or thrombocytopenia - Elevated liver enzymes indicating hepatic injury

When prescribing Meropenem, clinicians should consider several safety and handling precautions. - Renal impairment: adjust dose based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests during therapy. - History of seizures: use with caution as the drug may lower seizure threshold. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Drug interactions: review concomitant medications for potential interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem can interact with other medicines, affecting efficacy or toxicity.

Major Interactions (Avoid): - Valproic acid: reduced serum levels may precipitate seizure breakthrough. - Probenecid: increased meropenem concentrations can raise toxicity risk. - Cytotoxic agents (e.g., cyclophosphamide): additive nephrotoxicity may occur.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Aminoglycosides: watch for combined nephrotoxic effects. - Anticoagulants (warfarin): monitor INR for potential alteration of anticoagulant effect.